Announcement of Resolutions of Tonghua Dongbao’s 2025 Annual Shareholders’ Meeting
Securities code: 600867 Securities abbreviation: Tonghua Dongbao Announcement number: 2026-027 Tonghua Dongbao Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2025 Annual Shareholders Meeting
The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the announcement content, and assume legal responsibility for the authenticity, accuracy and completeness of its content.
Important content reminder:
Is there any veto resolution at this meeting: None
1. Meeting convening and attendance
(1) Time of the shareholders’ meeting: May 12, 2026
(2) Location of shareholders’ meeting: Company conference room
(3) Common shareholders attending the meeting and preference shareholders whose voting rights have been restored and their holdings:
Number of shareholders and proxies attending the meeting 955
Total number of shares with voting rights held by shareholders attending the meeting (shares) 886,074,900
The number of voting shares held by shareholders attending the meeting accounts for the company’s voting shares.
Proportion of total number of copies (%) 45.2975
(4) Whether the voting method complies with the provisions of the "Company Law" and the "Articles of Association", the status of the meeting, etc.
This meeting was convened by the company's board of directors, and the company's chairman Mr. Li Jiahong presided over the meeting. The meeting adopts a voting method that combines on-site voting and online voting. The convening and holding of this meeting complied with the relevant provisions of the Company Law and the Articles of Association.
(5) Attendance of company directors and board secretary
- The company has 9 current directors and 9 people are present; among them, Ms. Bi Yan, Ms. Xu Dai, and Ms. Xu Li are the sole directors of the company.
Established director
- Mr. Wu Lingxi, Secretary of the Board of Directors, attended this meeting as a non-voting delegate; senior management personnel of the Company also attended this meeting as a non-voting delegate.
2. Proposal review status
(1) Non-cumulative voting proposals
- Proposal Name: "2025 Board of Directors Work Report"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 884,197,836 99.7881 1,098,664 0.1239 778,400 0.0880
- Proposal Name: "Profit Distribution Plan for 2025"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 884,461,636 99.8179 1,014,864 0.1145 598,400 0.0676
- Proposal Name: "Proposal on Re-appointing Daxin Accounting Firm (Special General Partnership) as the Company's 2026 Financial Report Auditing Agency and Internal Control Auditing Agency"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 884,264,136 99.7956 1,079,164 0.1217 731,600 0.0827
- Proposal Name: "Proposal on the Implementation of Daily Related Transactions in 2025 and Expected Daily Related Transactions in 2026"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 238,013,673 99.1864 1,210,864 0.5045 741,400 0.3091
- Proposal Name: "Proposal on Developing the Company's Remuneration Management System for Directors and Senior Management"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 883,295,176 99.6862 1,981,024 0.2235 798,700 0.0903
- Proposal Name: "Proposal on Confirming the Remuneration of Directors in 2025"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 874,494,712 99.6401 2,348,241 0.2675 809,900 0.0924
- Proposal Name: "Proposal on the Remuneration Plan for Directors in 2026"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 874,462,012 99.6364 2,326,841 0.2651 864,000 0.0985
- Proposal Name: "Proposal on Providing Financial Assistance to Holding Subsidiaries"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 869,132,731 98.0879 16,138,269 1.8213 803,900 0.0908
(2) When major matters are involved, the voting status of shareholders below 5%
- Non-cumulative voting proposals
Agree Objection Abstain motion
Motion name Proportion Proportion Proportion number Number of votes Number of votes Number of votes (%) (%) (%)
"2025 Profit Distribution
2 73,479,826 97.8516 1,014,864 1.3514 598,400 0.7970 plan》
"About Daily Relations in 2025"
execution status of joint transactions and
4 54,954,706 96.5693 1,210,864 2.1277 741,400 1.3030 Estimated daily customs clearance in 2026
Joint Transaction Proposal"
"About confirming the 2025 fiscal year
6 71,934,949 95.7943 2,348,241 3.1271 809,900 1.0786 Proposal on Directors’ Remuneration》
"About the 2026 Directors of the Year"
7 71,902,249 95.7508 2,326,841 3.0986 864,000 1.1506 Remuneration Plan Proposal》
"About holding subsidiaries
8 Proposal to provide financial assistance 58,150,921 77.4384 16,138,269 21.4910 803,900 1.0706"
(3) Explanation of relevant circumstances regarding voting on motions
Proposal 4, Proposal 6, and Proposal 7 reviewed and approved at this shareholders' meeting are matters of avoidance of voting, and the controlling shareholders
Dongdongbao Industrial Group Co., Ltd. and related shareholders abstained from voting on matters requiring avoidance.
3. Lawyer’s testimony
(1) Law firm witnessing this shareholders’ meeting: Jilin Bingli Law Firm
Lawyers: Guo Shufen and Shang Bi
(2) Lawyer’s concluding comments:
The convening and holding procedures of the company's shareholders' meeting, the qualifications of personnel attending the shareholders' meeting and the voting procedures are all in compliance with the provisions of my country's laws, regulations, normative documents and the "Articles of Association", and the voting results are legal and valid. Announcement is hereby made.
Board of Directors of Tonghua Dongbao Pharmaceutical Co., Ltd.
May 13, 2026